Home
>
National Drug Code (NDC)
>
Eldepryl
Eldepryl - 39506-022-60 - (selegiline hydrochloride)
Drug Information of Eldepryl
| Product NDC: | 39506-022 |
| Proprietary Name: | Eldepryl |
| Non Proprietary Name: | selegiline hydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; selegiline hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Eldepryl
| Product NDC: | 39506-022 |
| Labeler Name: | Somerset Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA020647 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19960515 |
Package Information of Eldepryl
| Package NDC: | 39506-022-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (39506-022-60) |
NDC Information of Eldepryl
| NDC Code | 39506-022-60 |
| Proprietary Name | Eldepryl |
| Package Description | 60 CAPSULE in 1 BOTTLE (39506-022-60) |
| Product NDC | 39506-022 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | selegiline hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19960515 |
| Marketing Category Name | ANDA |
| Labeler Name | Somerset Pharmaceuticals Inc. |
| Substance Name | SELEGILINE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
